I.L. Dvornyk
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
I.L. Dvornyk has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Oksana V. Muravlova
POLTAVA STATE MEDICAL UNIVERSITY, POLTAVA, UKRAINE
3 shared publications - Zlatoslava O. Shaienko
POLTAVA STATE MEDICAL UNIVERSITY, POLTAVA, UKRAINE
2 shared publications - Iryna Anatoliivna Holovanova
POLTAVA STATE MEDICAL UNIVERSITY, POLTAVA, UKRAINE
1 shared publication - Iryna Yuriivna Lytovchenko
Poltava State Medical University of the Ministry of Health of Ukraine, Poltava, Ukraine
1 shared publication - L.B. Yerus
Poltava state medical university, Shevchenko str., 23, Poltava, 36011, Ukraine
1 shared publication - L.M. Syzova
Полтавський державний медичний університет
1 shared publication
Latest Publications
- Open Access
- 30 October 2023
- Published by Publishing House Zaslavsky in INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
- Vol. 19 (6) , 448-454
Diabetes mellitus and COVID-19: living with double risk
Background. The purpose is to analyze and summarize the studies conducted to determine the impact of COVID-19 on the course of diabetes mellitus and the manifestations of chronic complications of this disease. Materials and methods. We did the search in PubMed and ScienceDirect databases using the following line: “SARS-CoV-2 or COVID-19 and diabetes or hyperglycemia”. Results. It was found that in patients with diabetes, the severity of COVID-19 is increased. In particular, the number of those who needed intensive care or artificial ventilation has elevated. The same negative trend is noted for the overall mortality rate in patients with diabetes. It has been found that COVID-19 contributes to an increase in the development of diabetes, including diabetic ketoacidosis, hyperosmolar syndrome, brain stroke and mental health disorders, which can potentiate the effect of COVID-19 in enhancing the manifestations of diabetes and double risk for these patients. Along with this, the common pathways of the pathogenesis of diabetes and COVID-19 determine the bidirectionality of the interaction in their comorbidity. Conclusions. We have demonstrated numerous links between COVID-19 pathogenetic mechanisms and diabetes. Despite this, current research shows only modest evidence of an increased risk of metabolic, neurological, and psychiatric complications in patients with diabetes who had COVID-19. However, along with the direct impact of patients’ infection, the conditions of pandemic are also affected, which complicate access to the necessary care and should be taken into account when studying the clinical consequences of COVID-19 in patients with diabetes.
- 30 October 2023
- Published by Publishing House Zaslavsky in INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
- Vol. 19 (6) , 448-454
Open AccessDiabetes mellitus and COVID-19: living with double risk
Background. The purpose is to analyze and summarize the studies conducted to determine the impact of COVID-19 on the course of diabetes mellitus and the manifestations of chronic complications of this disease. Materials and methods. We did the search in PubMed and ScienceDirect databases using the following line: “SARS-CoV-2 or COVID-19 and diabetes or hyperglycemia”. Results. It was found that in patients with diabetes, the severity of COVID-19 is increased. In particular, the number of those who needed intensive care or artificial ventilation has elevated. The same negative trend is noted for the overall mortality rate in patients with diabetes. It has been found that COVID-19 contributes to an increase in the development of diabetes, including diabetic ketoacidosis, hyperosmolar syndrome, brain stroke and mental health disorders, which can potentiate the effect of COVID-19 in enhancing the manifestations of diabetes and double risk for these patients. Along with this, the common pathways of the pathogenesis of diabetes and COVID-19 determine the bidirectionality of the interaction in their comorbidity. Conclusions. We have demonstrated numerous links between COVID-19 pathogenetic mechanisms and diabetes. Despite this, current research shows only modest evidence of an increased risk of metabolic, neurological, and psychiatric complications in patients with diabetes who had COVID-19. However, along with the direct impact of patients’ infection, the conditions of pandemic are also affected, which complicate access to the necessary care and should be taken into account when studying the clinical consequences of COVID-19 in patients with diabetes.
- Open Access
- 30 June 2023
- Published by Dnipro State Medical University in Medicni perspektivi
- Vol. 28 (2) , 127-135
Prosthetic stomatitis in patients with diabetes mellitus: correction of psycho-emotional stress
A high level of chronic emotional stress affects the occurrence and increases the severity of diseases of the oral mucosa and internal pathology. The aim of the work is to increase the effectiveness of the treatment of prosthetic stomatitis in patients with diabetes mellitus against the background of psycho-emotional stress by correcting it. To objectify the state of psycho-emotional stress, in 2005-2015 and in 2022 psychological testing was carried out by the D. Taylor method on 230 people aged 19-70 years, among whom 85 patients were diagnosed with diabetes mellitus – the main group; 145 people were without internal diseases – two control groups. General examination and treatment of patients of the main group – 46 women and 39 men aged 19-70 years was carried out by endocrinologists according to the relevant protocols. Dental examination and treatment of prosthetic stomatitis was carried out in 12 patients with diabetes mellitus who had a high level of general anxiety according to the D. Taylor method. Own method of treatment: after the correction of the prosthesis, sanitation of the oral cavity, applications of thiotriazoline 2% ointment, a course of 7-10 days on the areas of the prosthetic bed, most often subject to trauma were prescribed. For general therapy, an additional stress-protective drug which corrects psycho-emotional stress in patients with diabetes mellitus was prescribed, thiotriazoline, orally, for 30 days. In patients of the main group, a high level of general personal anxiety was recorded in 21.63% of respondents and an average level with a tendency to high – in 54.29%. In many cases, the dentist should know the level of the patient's psycho-emotional stress in order to justify an individual approach to therapeutic measures and maintenance therapy in the choice of drugs and methods. The proposed method of treatment of prosthetic stomatitis has an individual approach, includes the stress-protective drug thiotriazoline, which corrects psycho-emotional stress, allowing to achieve a stable remission of the disease.
- 30 June 2023
- Published by Dnipro State Medical University in Medicni perspektivi
- Vol. 28 (2) , 127-135
Open AccessProsthetic stomatitis in patients with diabetes mellitus: correction of psycho-emotional stress
A high level of chronic emotional stress affects the occurrence and increases the severity of diseases of the oral mucosa and internal pathology. The aim of the work is to increase the effectiveness of the treatment of prosthetic stomatitis in patients with diabetes mellitus against the background of psycho-emotional stress by correcting it. To objectify the state of psycho-emotional stress, in 2005-2015 and in 2022 psychological testing was carried out by the D. Taylor method on 230 people aged 19-70 years, among whom 85 patients were diagnosed with diabetes mellitus – the main group; 145 people were without internal diseases – two control groups. General examination and treatment of patients of the main group – 46 women and 39 men aged 19-70 years was carried out by endocrinologists according to the relevant protocols. Dental examination and treatment of prosthetic stomatitis was carried out in 12 patients with diabetes mellitus who had a high level of general anxiety according to the D. Taylor method. Own method of treatment: after the correction of the prosthesis, sanitation of the oral cavity, applications of thiotriazoline 2% ointment, a course of 7-10 days on the areas of the prosthetic bed, most often subject to trauma were prescribed. For general therapy, an additional stress-protective drug which corrects psycho-emotional stress in patients with diabetes mellitus was prescribed, thiotriazoline, orally, for 30 days. In patients of the main group, a high level of general personal anxiety was recorded in 21.63% of respondents and an average level with a tendency to high – in 54.29%. In many cases, the dentist should know the level of the patient's psycho-emotional stress in order to justify an individual approach to therapeutic measures and maintenance therapy in the choice of drugs and methods. The proposed method of treatment of prosthetic stomatitis has an individual approach, includes the stress-protective drug thiotriazoline, which corrects psycho-emotional stress, allowing to achieve a stable remission of the disease.
- Open Access
- 30 June 2023
- Published by Publishing House Zaslavsky in INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
- Vol. 19 (4) , 295-299
Aspects of the development of hypothyroid cardiomyopathy associated with chronic systemic inflammation
Background. Cardiovascular manifestations are rated first among the symptoms of hypothyroidism. Since the highest prevalence of both coronary heart disease (CHD) and hypothyroidism is observed in the age group over 50 years old, the problem of combination of these nosologies in older people is increasing. Aim of the study is to investigate the structural and functional state of the left ventricular myocardium in hypothyroidism and CHD associated with chronic systemic inflammation. Materials and methods. To reach the objectives of the study, a randomized controlled clinical trial has been conducted in parallel groups of patients with hypothyroidism, CHD and combination of both. To form the main group, a screening analysis of 556 medical histories of patients with hypothyroidism and CHD during the period of 2006–2015 has been made, which were selected for further study. Results. It has been found that myocardial hypertrophy develops in all groups of patients, a decrease in thyroid function leads to remodeling of the left ventricular myocardium with the development of eccentric hypertrophy and the progression of systolic heart failure in comorbidity. A direct correlation between reduced ejection fraction and elevated interleukin-8 level has been detected. Evaluation of the state of chronic systemic inflammation revealed a significant increase in the level of interleukin-8 in patients with coronary heart disease associated with hypothyroidism (7.66 ± 2.18 pg/ml; p < 0.05). This indicate that the persistence of pro-inflammatory state in patients with combined pathology is a negative prognostic factor for the development of cardiovascular complications. Conclusion. During echocardioscopy of patients with hypothyroidism, the impaired central hemodynamics can be determined by the indicators of the diastolic and systolic heart function. In patients with isolated hypothyroidism and in combination with coronary heart disease, thickening of the left ventricular myocardial walls is noted, which proves the specificity of changes in the heart geometry that leads to the development of eccentric hypertrophy. This can be considered as the marker of a “hypothyroid” heart whose severity can determine the severity of hypothyroidism. Activation of chronic systemic inflammation is more pronounced in conditions of comorbidity, with a negative prognostic effect on the state of the cardiovascular system.
- 30 June 2023
- Published by Publishing House Zaslavsky in INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine)
- Vol. 19 (4) , 295-299
Open AccessAspects of the development of hypothyroid cardiomyopathy associated with chronic systemic inflammation
Background. Cardiovascular manifestations are rated first among the symptoms of hypothyroidism. Since the highest prevalence of both coronary heart disease (CHD) and hypothyroidism is observed in the age group over 50 years old, the problem of combination of these nosologies in older people is increasing. Aim of the study is to investigate the structural and functional state of the left ventricular myocardium in hypothyroidism and CHD associated with chronic systemic inflammation. Materials and methods. To reach the objectives of the study, a randomized controlled clinical trial has been conducted in parallel groups of patients with hypothyroidism, CHD and combination of both. To form the main group, a screening analysis of 556 medical histories of patients with hypothyroidism and CHD during the period of 2006–2015 has been made, which were selected for further study. Results. It has been found that myocardial hypertrophy develops in all groups of patients, a decrease in thyroid function leads to remodeling of the left ventricular myocardium with the development of eccentric hypertrophy and the progression of systolic heart failure in comorbidity. A direct correlation between reduced ejection fraction and elevated interleukin-8 level has been detected. Evaluation of the state of chronic systemic inflammation revealed a significant increase in the level of interleukin-8 in patients with coronary heart disease associated with hypothyroidism (7.66 ± 2.18 pg/ml; p < 0.05). This indicate that the persistence of pro-inflammatory state in patients with combined pathology is a negative prognostic factor for the development of cardiovascular complications. Conclusion. During echocardioscopy of patients with hypothyroidism, the impaired central hemodynamics can be determined by the indicators of the diastolic and systolic heart function. In patients with isolated hypothyroidism and in combination with coronary heart disease, thickening of the left ventricular myocardial walls is noted, which proves the specificity of changes in the heart geometry that leads to the development of eccentric hypertrophy. This can be considered as the marker of a “hypothyroid” heart whose severity can determine the severity of hypothyroidism. Activation of chronic systemic inflammation is more pronounced in conditions of comorbidity, with a negative prognostic effect on the state of the cardiovascular system.